Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 344 entries
View as:

Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05595590 Org: User:
Start: 10/20/22 End: 10/19/26 Due: 10/19/27

Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06409429 Org: User:
Start: 05/01/24 End: 05/30/27 Due: 05/30/28

AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT06489197 Org: User:
Start: 11/16/24 End: 08/30/27 Due: 08/30/28

A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT06717009 Org: User:
Start: 01/31/25 End: 10/31/27 Due: 10/31/28

Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.

Phase: N/A Priority: Normal
NCT ID: NCT05620498 Org: User:
Start: 09/08/22 End: 03/31/24 Due: 03/31/25

Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.

Phase: N/A Priority: Normal
NCT ID: NCT04245930 Org: User:
Start: 01/01/20 End: 12/31/22 Due: 12/31/23

A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02776527 Org: User:
Start: 04/30/16 End: 04/30/17 Due: 04/30/18

Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05084677 Org: User:
Start: 01/01/21 End: 12/31/24 Due: 12/31/25

A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05997147 Org: User:
Start: 05/01/23 End: 08/30/23 Due: 08/30/24

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

Phase: N/A Priority: Normal
NCT ID: NCT06061146 Org: User:
Start: 10/05/23 End: 10/01/26 Due: 10/01/27

Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC

Phase: N/A Priority: Normal
NCT ID: NCT05077839 Org: User:
Start: 09/01/21 End: 08/31/25 Due: 08/31/26

Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05560308 Org: User:
Start: 09/30/22 End: 08/23/25 Due: 08/23/26

Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04900311 Org: User:
Start: 05/31/21 End: 12/31/25 Due: 12/31/26

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT04736186 Org: User:
Start: 05/16/20 End: 04/30/23 Due: 04/30/24

Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04782765 Org: User:
Start: 03/20/21 End: 03/20/25 Due: 03/20/26

Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )

Phase: N/A Priority: Normal
NCT ID: NCT04863079 Org: User:
Start: 05/01/21 End: 04/30/24 Due: 04/30/25

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06717464 Org: User:
Start: 11/12/24 End: 12/31/27 Due: 12/31/28

AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC

Phase: N/A Priority: Normal
NCT ID: NCT06472037 Org: User:
Start: 07/01/24 End: 07/01/25 Due: 07/01/26

Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor

Phase: N/A Priority: Normal
NCT ID: NCT04766827 Org: User:
Start: 12/12/20 End: 12/31/21 Due: 12/31/22

Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT06570447 Org: User:
Start: 05/15/25 End: 12/31/28 Due: 12/31/29

Early Detection of Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05596435 Org: User:
Start: 10/10/22 End: 10/12/24 Due: 10/12/25

Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression

Phase: N/A Priority: Normal
NCT ID: NCT06560528 Org: User:
Start: 09/01/24 End: 09/01/28 Due: 09/01/29

A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06997302 Org: User:
Start: 01/01/22 End: 12/31/25 Due: 12/31/26

Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02977429 Org: User:
Start: 10/31/16 End: 09/30/18 Due: 09/30/19

Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT06495515 Org: User:
Start: 08/01/24 End: 06/30/26 Due: 06/30/27